P-TEFb is not an essential elongation factor for the intronless human U2 snRNA and histone H2b genes.
about
Ser7 phosphorylation of the CTD recruits the RPAP2 Ser5 phosphatase to snRNA genesThe little elongation complex regulates small nuclear RNA transcriptionThe little elongation complex functions at initiation and elongation phases of snRNA gene transcriptionIntegrator: surprisingly diverse functions in gene expressionFormation of the 3' end of histone mRNA: getting closer to the endTranscription termination by nuclear RNA polymerasesmicroRNA machinery is an integral component of drug-induced transcription inhibition in HIV-1 infection.Demethylation of the coding region triggers the activation of the human testis-specific PDHA2 gene in somatic tissues.Application of a novel strategy of engineering conditional alleles to a single exon gene, Sox2.Effect of mimetic CDK9 inhibitors on HIV-1-activated transcription.MLL-AF9 and MLL-ENL alter the dynamic association of transcriptional regulators with genes critical for leukemia.Nucleases of the metallo-beta-lactamase family and their role in DNA and RNA metabolism.The Yin and Yang of P-TEFb regulation: implications for human immunodeficiency virus gene expression and global control of cell growth and differentiationHerpes Simplex Virus 1 (HSV-1) ICP22 protein directly interacts with cyclin-dependent kinase (CDK)9 to inhibit RNA polymerase II transcription elongationH3K4 tri-methylation provides an epigenetic signature of active enhancers.Non-mRNA 3' end formation: how the other half livesHerpes simplex virus immediate-early protein ICP22 triggers loss of serine 2-phosphorylated RNA polymerase IIComplex effects of flavopiridol on the expression of primary response genesHuman U2 snRNA genes exhibit a persistently open transcriptional state and promoter disassembly at metaphaseHistone H3K36 trimethylation is essential for multiple silencing mechanisms in fission yeast.Selective control of gene expression by CDK9 in human cellssnRNA 3' end formation: the dawn of the Integrator complex.A kinase-independent activity of Cdk9 modulates glucocorticoid receptor-mediated gene induction.Inhibiting eukaryotic transcription: Which compound to choose? How to evaluate its activity?Cotranscriptional RNA checkpoints.Making ends meet: coordination between RNA 3'-end processing and transcription initiation.Overview of CDK9 as a target in cancer research.CDK9 inhibitors define elongation checkpoints at both ends of RNA polymerase II-transcribed genes.Cyclin-dependent kinase 9 links RNA polymerase II transcription to processing of ribosomal RNAControl of inducible gene expression by signal-dependent transcriptional elongation.CTCF regulates NELF, DSIF and P-TEFb recruitment during transcription.Regulation of expression of human RNA polymerase II-transcribed snRNA genesIdentification of sequences in herpes simplex virus type 1 ICP22 that influence RNA polymerase II modification and viral late gene expression.Chemical-genomic dissection of the CTD code.Transcribing RNA polymerase II is phosphorylated at CTD residue serine-7.Serine-7 of the RNA polymerase II CTD is specifically required for snRNA gene expression.Efficient transcription through an intron requires the binding of an Sm-type U1 snRNP with intact stem loop II to the splice donorMED26 regulates the transcription of snRNA genes through the recruitment of little elongation complex.Human snRNA genes use polyadenylation factors to promote efficient transcription termination.Role of Ser7 phosphorylation of the CTD during transcription of snRNA genes.
P2860
Q24298880-678F0C15-BE8F-44D8-A39C-5F541E295EA8Q24300557-8DD93337-EE19-406E-8866-AD2592414568Q24316411-B76B013A-7CE5-49A8-AE34-9FD6C14B1971Q28081160-E0DAB23C-772E-4EDE-B685-97E1D018DFABQ28751417-16B226DD-FA7B-4B5C-8C1F-A25606451007Q29541446-F146B133-F026-4786-9A27-7E6668A1CD56Q33985168-5F431E12-48B2-49DD-B66F-F28AFCBFBD73Q34279573-824C40FA-9899-406F-AF4B-7EE26733644BQ34430025-C459A4AC-AA7F-4E36-8BCF-042A7F3273DDQ34514689-F6690623-DBA1-42CE-8026-18A55D1F1A66Q34571591-A5AA00D5-0091-47A3-AD5F-A5F59CA6D031Q34622114-F1B7007E-7C79-42B1-801C-12BC55C2FBECQ35072999-A8FAA3B7-F3F2-4A87-93D3-06C404DE3586Q35261303-643FF962-3204-42FB-BA15-D365FBF52509Q35422275-D36FD852-80B5-4B6C-9772-0819DE4AD6DAQ35524345-B7E8F269-1301-4A2B-A7CF-1F2C2B10F02EQ35857527-CA1942C8-43E9-40CD-ACE9-C760196D0703Q35920526-AED753D5-5CF0-4C05-848F-C4C5C68AE0D6Q36711222-56E46116-559D-4365-AC35-1A8327FC9281Q36914566-5FA9DE49-23AF-483E-B3F0-B792823E01A4Q37437860-0D60DC34-DF24-4783-9A21-E49658456B44Q37672314-976E96E6-6235-4930-ADF4-2ECD1CB59FB6Q37701748-5E6EE944-5964-44AA-A43A-6C62DCA8642DQ37933073-1C15C890-19B4-472A-98C5-36561ACEEECDQ37961735-9B1A021D-3053-4297-99D2-E5E52F51064CQ38085601-8490A933-075D-4717-81C7-E1D689016A7FQ38696353-A0896F15-760C-494C-8DB2-2AD20DB3422BQ38890103-C92B6B08-F95F-4606-BA38-482B15682141Q39142936-324DF860-576B-4A51-83FD-167CDD6B7103Q39285490-1DE75778-F4A4-4904-B74E-EEF6B9A1A049Q39329169-9B7AA60B-136D-4E45-8011-E75BEAC7F29AQ39374135-6165851B-8EEB-45AC-B417-2A83F8B01C0FQ39923711-0B985D76-21D6-4207-AD05-69354B716A9EQ39975943-97178D03-E632-4902-BFF3-3C2F9C66DB0FQ40035560-4C6D76F4-A5FD-4EAB-AF63-642F0932F34FQ40035566-2914745F-5FB5-401C-8268-8CB43F884B13Q40704048-8F188B89-D590-48DB-98D5-2F1C3691598BQ41600259-2E04213F-6359-49A7-987E-7DBB5CF5B40FQ41837860-3BF9696C-A544-46D5-A4DC-65FB68877E72Q41886305-B993738F-5F25-43DD-AECF-E117520C7ACF
P2860
P-TEFb is not an essential elongation factor for the intronless human U2 snRNA and histone H2b genes.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
P-TEFb is not an essential elo ...... 2 snRNA and histone H2b genes.
@en
type
label
P-TEFb is not an essential elo ...... 2 snRNA and histone H2b genes.
@en
prefLabel
P-TEFb is not an essential elo ...... 2 snRNA and histone H2b genes.
@en
P2093
P2860
P356
P1433
P1476
P-TEFb is not an essential elo ...... 2 snRNA and histone H2b genes.
@en
P2093
Alice Taylor
Andrew Scurry
B Matija Peterlin
Joanne Medlin
Shona Murphy
P2860
P304
P356
10.1038/SJ.EMBOJ.7600876
P407
P577
2005-11-24T00:00:00Z